Name: The Use of Probiotics in the Treatment of Irritable Bowel Syndrome (en Inglés)
Price: 158.33 PEN
Availability: InStock
Author: Oliveira Santos, Monise ; Andréa Moura, Fabiana
ISBN: 9786207446124

portada The Use of Probiotics in the Treatment of Irritable Bowel Syndrome (en Inglés)

The Use of Probiotics in the Treatment of Irritable Bowel Syndrome (en Inglés)

Formato

Libro Físico

Autor

Monise Oliveira Santos

Fabiana Andréa Moura

Editorial

Our Knowledge Publishing

Idioma

Inglés

N° páginas

Encuadernación

Tapa Blanda

Dimensiones

22.9 x 15.2 x 0.3 cm

Peso

0.09 kg.

ISBN13

9786207446124

Categorías

Medicina: cuestiones generales

The Use of Probiotics in the Treatment of Irritable Bowel Syndrome (en Inglés)

Monise Oliveira Santos (Autor) · Fabiana Andréa Moura (Autor) · Our Knowledge Publishing · Tapa Blanda

Libro Nuevo Importado

Envío: 22 a 27 días háb.

S/ 351,84S/ 158,33

-55%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan 10 unidades

S/ 158,33

Llega entre el 24 Ago y el 01 Sep a CERCADO DE LIMA, Lima. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "The Use of Probiotics in the Treatment of Irritable Bowel Syndrome (en Inglés)"

Irritable Bowel Syndrome (IBS) is a gastrointestinal disorder whose predominant symptoms are abdominal pain or discomfort, accompanied by diarrhea and/or constipation. A single pharmacological or non-pharmacological therapy proves to be ineffective. Probiotics are showing promise. This book discusses epidemiological and pathophysiological aspects and seeks to determine the efficacy of the use of probiotics in the treatment of IBS. A systematic review was carried out in Pubmed, Sciencedirect and Scopus, using the combined keywords Irritable bowel syndrome and probiotics. The search was carried out from August to October 2015 and 16 studies were eligible. The results showed that 81.2% of the articles had positive effects. Lactobacillus was responsible for 75% of these effects. A dosage of 4 to 5 x 109 bacteria twice a day and a study time of 4 weeks were most common. The results indicate that probiotics are a promising strategy, but more clinical trials are needed with an appropriate design, longer evaluation time, standardization in dosages and identification of the isolated and synergistic effects of the species used.